Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression- and treatment-free following a single infusion as early as second line[1] Data ...
Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression and treatment-free following a single ...
Triple-class exposed patients with three prior lines of therapy in CARTITUDE-1 and CARTITUDE-4 achieved a median PFS of 50.4 months after a ...
Johnson & Johnson today announced final overall survival (OS) results from the Asia patients of the Phase 3 MARIPOSA study. Head-to-head comparison data versus osimertinib monotherapy showed ...
CAPE CANAVERAL SPACE FORCE STATION — The weather was looking pretty fine as SpaceX launched nearly 30 Starlink satellites on Wednesday morning. The Falcon 9 rocket sent up Starlink 10-22 mission from ...
KENNEDY SPACE CENTER — Despite a technical issue regarding the launch escape system, SpaceX was able to send up Axiom Space’s Ax-4 mission early Wednesday morning. The four astronauts — three of whom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results